Neutrophil count, lymphocyte count and neutrophil-to-lymphocyte ratio in relation to response to adjunctive dexamethasone treatment in community-acquired pneumonia

CONCLUSIONS: WBC count and/or neutrophil might be easily available biomarkers to guide selection of CAP patients who are more likely to benefit from adjunctive dexamethasone treatment. Future prospective trials are needed to confirm this predictive potential.PMID:34782191 | DOI:10.1016/j.ejim.2021.10.030
Source: European Journal of Internal Medicine - Category: Internal Medicine Authors: Source Type: research